Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma

NCT00863369

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: City of Hope Medical Center Duarte, California, United States

South Pasadena Cancer Center South Pasadena, California, United States

View Trial Details

Completed

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

NCT01386619

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations: Universitätsklinikum Frankfurt, Germany

University Hospital Basel, Switzerland

View Trial Details

Completed

Early Rehabilitation of Cancer Patients

NCT01588262

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
Locations: Department of Oncology and Medical Physics, Cancer center for Education and rehabilitation, Haukeland University Hospital Bergen, Norway

View Trial Details

Completed

Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb

NCT02012088

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Hospital Universitario de Alava Vitoria-Gasteiz, Alava, Spain

Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragon, Spain

Hospital de Cabueñes Gijón, Asturas, Spain

Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain

View all 14 locations

View Trial Details

Completed

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma

NCT05078593

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Geriatric Communication Skills Training Program for Oncology Clinicians

NCT03530969

Conditions: Bone Marrow Transplant, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

NCT00577278

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia

NCT03964259

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Virginia Commonwealth University/ Massey Cancer Center/ Children's Hospital of Richmond Richmond, Virginia, United States

View Trial Details

Completed

Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

NCT00075946

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Providence Saint Joseph Medical Center - Burbank Burbank, California, United States

View all 483 locations

View Trial Details

Completed

A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers

NCT06010680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: The First Affiliated Hospital of Suzhou University Suzhou, Jiangsu, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions